Total Payments
$51,282
2024 Payments
$5,081
Companies
31
Transactions
602
Medicare Patients
6,177
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$25,131 (49.0%)
Other$12,000 (23.4%)
Travel$6,892 (13.4%)
Consulting$6,200 (12.1%)
Education$1,059 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,131 | 564 | 49.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,000 | 11 | 23.4% |
| Travel and Lodging | $6,892 | 20 | 13.4% |
| Consulting Fee | $6,200 | 2 | 12.1% |
| Education | $1,059 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $29,959 | 182 | $0 (2024) |
| MML US, Inc. | $3,103 | 23 | $0 (2023) |
| Nevro Corp. | $2,986 | 102 | $0 (2024) |
| Medtronic, Inc. | $2,640 | 24 | $0 (2024) |
| PAINTEQ LLC | $2,501 | 26 | $0 (2024) |
| Saluda Medical Americas, Inc. | $1,680 | 29 | $0 (2024) |
| Abbott Laboratories | $1,436 | 15 | $0 (2024) |
| Nalu Medical, Inc. | $1,241 | 20 | $0 (2024) |
| Spinal Simplicity, LLC | $1,071 | 4 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $814.73 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,081 | 132 | Spinal Simplicity, LLC ($1,071) |
| 2023 | $7,489 | 146 | MML US, Inc. ($2,048) |
| 2022 | $21,320 | 145 | Boston Scientific Corporation ($15,509) |
| 2021 | $13,221 | 123 | Boston Scientific Corporation ($10,535) |
| 2020 | $4,173 | 56 | Boston Scientific Corporation ($2,443) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $8.14 | General |
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/01/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/26/2024 | Spinal Simplicity, LLC | LIBERTY SI (Device), HA MINUTEMAN G3-R | Food and Beverage | In-kind items and services | $95.45 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/25/2024 | Spinal Simplicity, LLC | LIBERTY SI (Device), HA MINUTEMAN G3-R | Travel and Lodging | In-kind items and services | $209.58 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/25/2024 | Spinal Simplicity, LLC | LIBERTY SI (Device), HA MINUTEMAN G3-R | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/17/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/01/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,735 | 2,892 | $1.3M | $297,009 |
| 2022 | 26 | 1,804 | 3,512 | $1.6M | $371,855 |
| 2021 | 31 | 2,276 | 4,745 | $2.0M | $483,570 |
| 2020 | 11 | 362 | 453 | $154,242 | $36,899 |
Total Patients
6,177
Total Services
11,602
Medicare Billing
$1.2M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 445 | 1,273 | $499,016 | $124,512 | 25.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 198 | 280 | $125,315 | $30,102 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 202 | 202 | $105,040 | $25,247 | 24.0% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 27 | 72 | $95,976 | $18,308 | 19.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 59 | 73 | $78,074 | $16,743 | 21.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 119 | 144 | $54,720 | $14,590 | 26.7% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Facility | 2023 | 22 | 51 | $56,202 | $9,553 | 17.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 54 | 67 | $28,900 | $7,194 | 24.9% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 25 | 30 | $31,812 | $6,463 | 20.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 40 | 51 | $25,840 | $6,123 | 23.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 105 | 131 | $21,961 | $5,431 | 24.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 59 | 73 | $21,024 | $5,236 | 24.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 54 | 62 | $21,390 | $4,513 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 61 | $16,958 | $4,285 | 25.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 54 | 67 | $16,600 | $4,103 | 24.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 40 | 51 | $14,668 | $3,615 | 24.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 39 | 40 | $10,400 | $2,998 | 28.8% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 15 | 15 | $28,980 | $2,389 | 8.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 25 | 29 | $9,265 | $2,269 | 24.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 20 | 25 | $8,277 | $1,827 | 22.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 21 | 28 | $8,330 | $645.22 | 7.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 47 | 51 | $5,049 | $510.29 | 10.1% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 13 | 16 | $1,408 | $354.40 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 471 | 1,743 | $671,834 | $165,422 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 187 | 187 | $97,240 | $23,499 | 24.2% |
About Dr. Ivan Urits, MD
Dr. Ivan Urits, MD is a Pain Medicine healthcare provider based in Wareham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1346635422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Urits, MD has received a total of $51,282 in payments from pharmaceutical and medical device companies, with $5,081 received in 2024. These payments were reported across 602 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($25,131).
As a Medicare-enrolled provider, Urits has provided services to 6,177 Medicare beneficiaries, totaling 11,602 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Wareham, MA
- Active Since 04/05/2015
- Last Updated 01/22/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1346635422
Products in Payments
- WaveWriter Alpha Prime 16 (Device) $11,419
- WAVEWRITER ALPHA (Device) $8,058
- General - Therapies (Device) $4,165
- ReActiv8 (Device) $3,103
- PAINTEQ (Device) $2,501
- VENASEAL (Device) $1,834
- GENERAL PAIN MANAGEMENT (Device) $1,777
- SPECTRA WAVEWRITER (Device) $1,639
- Senza (Device) $1,325
- Omnia (Device) $1,252
- Nalu Neurostimulation System (Device) $1,241
- GENERAL - PAIN MANAGEMENT (Device) $1,071
- Evoke SCS (Device) $876.36
- PROCLAIM (Device) $873.81
- General - Pain Management (Device) $873.71
- Iovera (Device) $814.73
- Evoke (Device) $803.14
- HA MINUTEMAN G3-R (Device) $646.96
- mild Device Kit (Device) $451.47
- INTELLIS ADAPTIVESTIM (Device) $437.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.